Provided by Tiger Trade Technology Pte. Ltd.

Carlsmed, Inc.

16.05
-0.4500-2.73%
Post-market: 16.00-0.0500-0.31%19:30 EDT
Volume:263.74K
Turnover:4.36M
Market Cap:437.08M
PE:-12.02
High:17.23
Open:16.49
Low:16.01
Close:16.50
52wk High:17.23
52wk Low:8.50
Shares:27.23M
Float Shares:15.67M
Volume Ratio:1.11
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3350
EPS(LYR):-2.1247
ROE:-66.14%
ROA:-28.19%
PB:5.19
PE(LYR):-7.55

Loading ...

Carlsmed Initiated at Buy by Needham

Dow Jones
·
Jul 01

Needham Initiates Carlsmed at Buy With $17 Price Target

MT Newswires Live
·
Jul 01

Carlsmed initiated with a Buy at Needham

TIPRANKS
·
Jul 01

Analysts’ Top Healthcare Picks: Tonix Pharma (TNXP), Carlsmed, Inc. (CARL)

TIPRANKS
·
Jul 01

Carlsmed Inc : Needham Initiates Coverage with Buy Rating; Price Target $17

THOMSON REUTERS
·
Jul 01

U.S. Research Roundup- Dow, Palo Alto Networks, Zions Bancorporation

Reuters
·
Jul 01

Carlsmed, Inc. (CARL) Gets a Buy from BTIG

TIPRANKS
·
Jun 24

Carlsmed Shareholders Back Directors and Auditor at Meeting

TIPRANKS
·
Jun 04

Carlsmed holds annual shareholder meeting, elects two directors

Reuters
·
Jun 04

Piper Sandler Sticks to Its Buy Rating for Carlsmed, Inc. (CARL)

TIPRANKS
·
May 06

Carlsmed, Inc. (CARL) Gets a Buy from Goldman Sachs

TIPRANKS
·
May 06

Carlsmed Price Target Maintained With a $23.00/Share by BTIG

Dow Jones
·
May 06

Zimmerman Reiterates Buy on Carlsmed After Strong Q1, Raises 2026 Outlook and Keeps $23 Price Target Unchanged

TIPRANKS
·
May 06

Carlsmed Earnings Call Highlights Growth, Rising Costs

TIPRANKS
·
May 06

Carlsmed reports Q1 EPS (32c), consensus (40c)

TIPRANKS
·
May 06

Carlsmed raises FY26 revenue view to $72M-$77M from $70M-$75M

TIPRANKS
·
May 06

Carlsmed Q1 EPS $(0.32) Beats $(0.41) Estimate, Sales $16.100M Beat $14.984M Estimate

Benzinga Earnings
·
May 06

Carlsmed Q1 FY26 net loss widens 51.8% to $8.7 million; revenue rises 58.2% to $16.1 million

Reuters
·
May 06

Carlsmed Inc Q1 Gross Margin 77.1%

THOMSON REUTERS
·
May 06

Carlsmed® Reports First Quarter 2026 Financial Results

GlobeNewswire
·
May 06